Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae Won Kim

Showing results (381-390 of 634) with videos related to

Pageof 64
Sort By:
Cancer Research and Treatment|December 19, 2015
Patterns of Failure and Prognostic Factors in Anal Cancer Treated with RadiotherapyKyoung Ju Kim, Jong Hoon Kim, Eun Kyung Choi, et al.
American Journal of Clinical Oncology|February 11, 2003
Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorinJin-Hee Ahn, Tae-Won Kim, Je-Hwan Lee, et al.
Investigational New Drugs|June 17, 2015
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignanciesKyu-pyo Kim, Seong Joon Park, Jeong-Eun Kim, et al.
Journal of Neuro-Oncology|February 22, 2011
Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapyJi Yeon Baek, Myoung Hee Kang, Yong Sang Hong, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2011
Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trialSe Hyun Kim, Sang Joon Shin, Sun Young Kim, et al.
Geroscience|March 3, 2026
Age-related increase of NLRC4 inflammasome and TGF-β1 signaling exacerbates airway inflammation and remodeling in asthmaJin-Hwa Kim, Hyun-Tae Kim, Jeong-Won Kim, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Clinical evaluation of incadronate in korean patients with malignancy-associated hypercalcemia: An open-label, multicenter studySung-Bae Kim, Jung Shin Lee, Heung Tae Kim, et al.
Journal of Surgical Oncology|May 3, 2008
Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs)Sun Jin Sym, Min-Hee Ryu, Jae-Lyun Lee, et al.
JCO Precision Oncology|January 20, 2022
International Harmonization of Provisional Diagnostic Criteria for <i>ERBB2</i>-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing PanelSatoshi Fujii, Anthony M Magliocco, Jihun Kim, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2009
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancerInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.
Pageof 64

Showing results (381-390 of 634) with videos related to

Sort By:
Pageof 64
Cancer Research and Treatment|December 19, 2015
Patterns of Failure and Prognostic Factors in Anal Cancer Treated with RadiotherapyKyoung Ju Kim, Jong Hoon Kim, Eun Kyung Choi, et al.
American Journal of Clinical Oncology|February 11, 2003
Oral doxifluridine plus leucovorin in metastatic colorectal cancer: randomized phase II trial with intravenous 5-fluorouracil plus leucovorinJin-Hee Ahn, Tae-Won Kim, Je-Hwan Lee, et al.
Investigational New Drugs|June 17, 2015
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignanciesKyu-pyo Kim, Seong Joon Park, Jeong-Eun Kim, et al.
Journal of Neuro-Oncology|February 22, 2011
Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapyJi Yeon Baek, Myoung Hee Kang, Yong Sang Hong, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2011
Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trialSe Hyun Kim, Sang Joon Shin, Sun Young Kim, et al.
Geroscience|March 3, 2026
Age-related increase of NLRC4 inflammasome and TGF-β1 signaling exacerbates airway inflammation and remodeling in asthmaJin-Hwa Kim, Hyun-Tae Kim, Jeong-Won Kim, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Clinical evaluation of incadronate in korean patients with malignancy-associated hypercalcemia: An open-label, multicenter studySung-Bae Kim, Jung Shin Lee, Heung Tae Kim, et al.
Journal of Surgical Oncology|May 3, 2008
Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs)Sun Jin Sym, Min-Hee Ryu, Jae-Lyun Lee, et al.
JCO Precision Oncology|January 20, 2022
International Harmonization of Provisional Diagnostic Criteria for <i>ERBB2</i>-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing PanelSatoshi Fujii, Anthony M Magliocco, Jihun Kim, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2009
Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancerInkeun Park, Jae-Lyun Lee, Min-Hee Ryu, et al.
Pageof 64